纽维克蒂斯制药 NVCT
$20.91 +$3.15 (+17.74%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.00 +0.43%
开盘$18.01
昨收$17.76
当日区间$17.80 – $21.05
成交量258.7K
市值$719.07M
市盈率（TTM）–
股息率–
NVCT 相关新闻
匹配 Nuvectis Pharma 或代码 NVCT 的头条新闻，按最新排序。
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $39
- Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34 正面
- Cantor Fitzgerald Initiates Nuvectis Pharma(NVCT.US) With Buy Rating
- Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $33
- Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $33 正面
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $30 正面
- Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $22 正面
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $39 正面
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $13
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $13 正面
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $17
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $10
- Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB)
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30
暂无评论——快来第一个聊聊 NVCT。
登录后参与讨论。